RxDoctor Payments Data

Daryl Parker, MD

Emergency Medicine · Saline, MINPI 1427006519

Payments from drug & device makers

$1,069in general payments, 2019–2025

Across 65 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$155
  • UCB, Inc.$143
  • Amgen$132
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$92
  • Supernus Pharmaceuticals, Inc.$90
  • Alkermes, Inc.$88
  • plus $368 from 14 others

What the payments were for

  • Food & beverage$1,069100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,069 in reported general payments places this provider in the 95th percentile of 2,532 emergency medicine providers in Michigan.

See all emergency medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$59,763
Medicare patients
246
Services billed
488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide111$131,899
EliquisApixaban94$90,573
JanuviaSitagliptin Phosphate83$63,448
OzempicSemaglutide28$35,107
TrintellixVortioxetine Hydrobromide35$30,457
MounjaroTirzepatide26$27,357
OxycontinOxycodone Hcl15$24,696
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$24,344
TradjentaLinagliptin20$16,405
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen809$16,356
JardianceEmpagliflozin20$14,179
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl43$12,113
LinzessLinaclotide19$9,774
Albuterol Sulfate HfaAlbuterol Sulfate220$8,838
Combivent RespimatIpratropium/Albuterol Sulfate13$7,418

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$43$159,256137 claims
PfizerEliquis$26$90,57394 claims
AbbVieLinzess$155$9,77419 claims
AstraZenecaSymbicort$68$6,33519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,532 emergency medicine providers in Michigan.

Other emergency medicine in Saline

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →